EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SMARCA2 and SMARCA4 Participate in DNA Damage Repair

Lily Yu, Duo Wu

Frontiers in Bioscience-Landmark · 2024

DOI: 10.31083/j.fbl2907262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Lily Yu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Transcription Factors, DNA Helicases, Nuclear Proteins, DNA Damage. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hangzhou City Leading Innovation and Entrepreneurship Team, "Pioneer" and "Leading Goose" R&D Program of Zhejiang, Westlake University Education Foundation, and Westlake Laboratory of Life Sciences and Biomedicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The switching/sucrose non-fermentable (SWI/SNF) Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A (SMARCA) member 2 and member 4 (SMARCA2/4) are paralogs and act as the key enzymatic subunits in the SWI/SNF complex for chromatin remodeling. However, the role of SMARCA2/4 in DNA damage response remains unclear.

Methods

Laser microirradiation assays were performed to examine the key domains of SMARCA2/4 for the relocation of the SWI/SNF complex to DNA lesions. To examine the key factors that mediate the recruitment of SMARCA2/4, the relocation of SMARCA2/4 to DNA lesions was examined in HeLa cells treated with inhibitors of Ataxia-telangiectasia-mutated (ATM), Ataxia telangiectasia and Rad3-related protein (ATR), CREB-binding protein (CBP) and its homologue p300 (p300/CBP), or Poly (ADP-ribose) polymerase (PARP) 1/2 as well as in H2AX-deficient HeLa cells. Moreover, by concomitantly suppressing SMARCA2/4 with the small molecule inhibitor FHD286 or Compound 14, the function of SMARCA2/4 in Radiation sensitive 51 (RAD51) foci formation and homologous recombination repair was examined. Finally, using a colony formation assay, the synergistic effect of PARP inhibitors and SMARCA2/4 inhibitors on the suppression of tumor cell growth was examined.

Results

We show that SMARCA2/4 relocate to DNA lesions in response to DNA damage, which requires their ATPase activities. Moreover, these ATPase activities are also required for the relocation of other subunits in the SWI/SNF complex to DNA lesions. Interestingly, the relocation of SMARCA2/4 is independent of γH2AX, ATM, ATR, p300/CBP, or PARP1/2, indicating that it may directly recognize DNA lesions as a DNA damage sensor. Lacking SMARCA2/4 prolongs the retention of γH2AX, Ring Finger Protein 8 (RNF8) and Breast cancer susceptibility gene 1 (BRCA1) at DNA lesions and impairs RAD51-dependent homologous recombination repair. Furthermore, the treatment of an SMARCA2/4 inhibitor sensitizes tumor cells to PARP inhibitor treatment.

Conclusions

This study reveals SMARCA2/4 as a DNA damage repair factor for double-strand break repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsDNA HelicasesNuclear ProteinsDNA DamageDNA RepairHumansHeLa CellsRad51 RecombinasePoly(ADP-ribose) Polymerase InhibitorsHistonesAtaxia Telangiectasia Mutated ProteinsBRCA1 Protein

Stichwörter der Autor:innen

DNA damage responseDNA repairSWI/SNF complex

Substanzen

SMARCA4 protein, humanTranscription FactorsSMARCA2 protein, humanDNA HelicasesNuclear ProteinsRad51 RecombinasePoly(ADP-ribose) Polymerase InhibitorsHistonesAtaxia Telangiectasia Mutated ProteinsBRCA1 Protein

Autor:innen und Institutionen

  • Department of Biological Sciences, University of Chicago, Chicago, IL 60637, USA.
  • SynRx Therapeutics, Chicago, IL 60642, USA.
  • School of Life Sciences, Westlake University, 310030 Hangzhou, Zhejiang, China.

Förderung

  • Hangzhou City Leading Innovation and Entrepreneurship Team
  • "Pioneer" and "Leading Goose" R&D Program of Zhejiang
  • Westlake University Education Foundation, and Westlake Laboratory of Life Sciences and Biomedicine
  • “Pioneer” and “Leading Goose” R&D Program of Zhejiang

Zitieren

APA

Yu, L., & Wu, D. (2024). SMARCA2 and SMARCA4 Participate in DNA Damage Repair. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2907262

Vancouver

Yu L, Wu D. SMARCA2 and SMARCA4 Participate in DNA Damage Repair. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2907262

BibTeX
@article{Yu2024,
  author = {Yu, Lily and Wu, Duo},
  title = {SMARCA2 and SMARCA4 Participate in DNA Damage Repair},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  doi = {10.31083/j.fbl2907262}
}
Kostenlos starten →